These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 29183000)

  • 41. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
    Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
    Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein kinase C alpha expression in normal breast, ductal carcinoma in situ and invasive ductal carcinoma.
    Ainsworth PD; Winstanley JH; Pearson JM; Bishop HM; Garrod DR
    Eur J Cancer; 2004 Oct; 40(15):2269-73. PubMed ID: 15454252
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lymph-node metastases in invasive lobular carcinoma are different from those in ductal carcinoma of the breast.
    Fernández B; Paish EC; Green AR; Lee AH; Macmillan RD; Ellis IO; Rakha EA
    J Clin Pathol; 2011 Nov; 64(11):995-1000. PubMed ID: 21712309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
    El Sharkawy SL; Farrag AR
    Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast density, scintimammographic (99m)Tc(V)DMSA uptake, and calcitonin gene related peptide (CGRP) expression in mixed invasive ductal associated with extensive in situ ductal carcinoma (IDC + DCIS) and pure invasive ductal carcinoma (IDC): correlation with estrogen receptor (ER) status, proliferation index Ki-67, and histological grade.
    Papantoniou V; Sotiropoulou E; Valsamaki P; Tsaroucha A; Sotiropoulou M; Ptohis N; Stipsanelli A; Dimitrakakis K; Marinopoulos S; Tsiouris S; Antsaklis A
    Breast Cancer; 2011 Oct; 18(4):286-91. PubMed ID: 20143189
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.
    Cao AY; He M; Liu ZB; Di GH; Wu J; Lu JS; Liu GY; Shen ZZ; Shao ZM
    Ann Surg Oncol; 2012 Sep; 19(9):3019-27. PubMed ID: 22451233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.
    Zengel B; Yararbas U; Duran A; Uslu A; Elıyatkın N; Demırkıran MA; Cengiz F; Şimşek C; Postacı H; Vardar E; Durusoy R
    Breast Cancer; 2015 Jul; 22(4):374-81. PubMed ID: 23925582
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphatic vessel assessment by podoplanin (D2-40) immunohistochemistry in breast cancer.
    Wahal SP; Goel MM; Mehrotra R
    J Cancer Res Ther; 2015; 11(4):798-804. PubMed ID: 26881521
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Accompanying DCIS in breast cancer patients with invasive ductal carcinoma is predictive of improved local recurrence-free survival.
    Dieterich M; Hartwig F; Stubert J; Klöcking S; Kundt G; Stengel B; Reimer T; Gerber B
    Breast; 2014 Aug; 23(4):346-51. PubMed ID: 24559611
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy.
    Jakub JW; Drake FD; Pippas AW; Gardner M; Fraile RJ; Giuliano R; Pendas S; Reintgen DS
    Cancer Control; 2003; 10(5):411-3. PubMed ID: 14581896
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetic pathways in the evolution of breast ductal carcinoma in situ.
    Farabegoli F; Champeme MH; Bieche I; Santini D; Ceccarelli C; Derenzini M; Lidereau R
    J Pathol; 2002 Mar; 196(3):280-6. PubMed ID: 11857490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recognizing breast ductal carcinoma in situ on fine-needle aspiration: a diagnostic dilemma.
    Guo HQ; Zhang ZH; Zhao H; Zhao LL; Pan QJ
    Diagn Cytopathol; 2013 Aug; 41(8):710-5. PubMed ID: 23729369
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of heterogeneity in breast cancer immunophenotype at ductal carcinoma
    Rohilla M; Bal A; Singh G; Joshi K
    J Cancer Res Ther; 2016; 12(4):1249-1256. PubMed ID: 28169235
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic significance of infiltrating immune cell subtypes in invasive ductal carcinoma of the breast.
    Xu Y; Lan S; Zheng Q
    Tumori; 2018 Jun; 104(3):196-201. PubMed ID: 28430349
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.
    Steinman S; Wang J; Bourne P; Yang Q; Tang P
    Ann Clin Lab Sci; 2007; 37(2):127-34. PubMed ID: 17522367
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mucinous metaplasia of breast carcinoma with macrocystic transformation resembling ovarian mucinous cystadenocarcinoma in a case of synchronous bilateral infiltrating ductal carcinoma.
    Lee SH; Chaung CR
    Pathol Int; 2008 Sep; 58(9):601-5. PubMed ID: 18801076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers.
    Kelly T; Kechelava S; Rozypal TL; West KW; Korourian S
    Mod Pathol; 1998 Sep; 11(9):855-63. PubMed ID: 9758365
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonal profiling of mixed lobular and ductal carcinoma revealed by multiplex ligation-dependent probe amplification and fluorescence in situ hybridization.
    Tajiri R; Inokuchi M; Sawada-Kitamura S; Kawashima H; Nakamura R; Oyama T; Dobashi Y; Ooi A
    Pathol Int; 2014 May; 64(5):231-6. PubMed ID: 24888777
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Invasive apocrine carcinoma of the breast: clinicopathologic features of 57 patients.
    Tanaka K; Imoto S; Wada N; Sakemura N; Hasebe K
    Breast J; 2008; 14(2):164-8. PubMed ID: 18248561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.